The arrests of top executives who strategically and illegally marketed the over prescribing of fentanyl spray will have to answer in the court of law. This marks one of the first instances where individuals at pharmaceutical companies are being held personally accountable for their unethical and illegal business practices that led to the opiate epidemic.
You may recall seeing the drug fentanyl associated with dozens of overdose articles. The substance is extremely potent and used as a cutting agent for the street drug heroin.
Even though opiate prescriptions are now carefully being watched and regulated there are other drugs that can now be just as easily exploited. These include medications containing buprenorphine. This is a synthetic drug which is used to assist addicts in stopping their dependency to opiates. It can be effective if used properly but can just as easily be abused and overprescribed as opiates themselves.
AARG view: We believe that personal accountability for reckless business decision making is a productive way of minimizing pharmaceutical companies boundary less sales tactics and market schemes. In turn, limiting the amount of overprescribing from the medical industry. It is imperative that pharmaceutical industry decision makers realize that their business actions could affect their personal lives. Rampant abuse of drugs containing buprenorphine is likely if not carefully managed.
If you know someone suffering from drug or alcohol dependence and aren’t sure where to turn contact AARG. We can assist you with the entire process of getting those you care about on the right path. email@example.com